The CounterACT Network is comprised of Contracts, Projects, Research Centers and Government Labs
In addition to our Center, four other Centers of Excellence were initiated by the CounterACT program:
Center for Catalytic Bioscavenger Medical Defense Research II: Discovery, Formulation, & Preclinical Evaluation
Douglas M. Cerasoli, Ph.D.
U.S. Army Medical Research Institute of Chemical Defense
UMDNJ/Rutgers University CounterACT Research Center of Excellence
Jeffrey D. Laskin, Ph.D.
RBHS - Robert Wood Johnson Medical School
Novel Anticonvulsant and Neuroprotective Therapies for TETS and OP Intoxication
Pamela J. Lein, Ph.D.
University of California, Davis
A Discovery and Development Pipeline for Cyanide Countermeasures
Calum A. MaCrae, M.D., Ph.D.
Brigham and Women's Hospital